Funded Tech Companies
Enlaza Therapeutics
Enlaza Therapeutics, based in La Jolla, received equity investments from Lightspeed Venture Partners, Frazier Life Sciences and Avalon Ventures.
Company Overview
Company Name
Enlaza Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
11099 North Torrey Pines Rd 280
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Enlaza is creating a groundbreaking new class of protein therapeutics that deliver more efficacious and safer treatments for patients. Enlaza's breakthrough War-LockTM technology enables generation of unique, highly-selective biologic drugs that are engineered to become warheads with the capacity to irreversibly lock to disease related targets. We leverage our novel synthetic biology platform, coupled with proprietary amino acids, to precision-engineer biological medicines with improved efficacy and safety profiles.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/19/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sergio Duron
Chief Scientific Officer
Analeah Heidt
Co-Founder
Sanford Madigan
Vice President
Sergio Duron
Vice President
Emily Rowell
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs